---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-129912"
form_type: "8-K"
ticker: "CGTX"
cik: "0001455365"
company_name: "COGNITION THERAPEUTICS INC"
filed_at: "2022-12-23T23:59:59+00:00"
generated_at: "2026-06-20T23:17:41.750305+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Cognition Therapeutics enters $40M ATM equity offering with Cantor and B. Riley

## Summary
- Entered Controlled Equity Offering Sales Agreement with Cantor Fitzgerald and B. Riley Securities.
- May sell up to $40 million of common stock in at-the-market offerings from time to time.
- Agents will receive a commission of 3.0% of gross proceeds from sales.
- Offering is subject to effectiveness of a registration statement on Form S-3 filed same day.
- Company is not obligated to make any sales under the agreement.

## SEC filing metadata
- accession: 0001104659-22-129912
- form_type: 8-K
- ticker: CGTX
- cik: 0001455365
- company_name: COGNITION THERAPEUTICS INC
- filed_at: 2022-12-23T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1455365/000110465922129912/0001104659-22-129912-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1455365/000110465922129912/tm2233391d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-129912
- JSON: https://secwatch.observer/filing/0001104659-22-129912.json
- Plain text: https://secwatch.observer/filing/0001104659-22-129912.txt

## Key facts
- Material Agreements
  COGNITION THERAPEUTICS INC entered into Sales Agreement with Cantor Fitzgerald & Co. and B. Riley Securities, Inc. valued at up to $40 million (effective 2022-12-23).
  - Action: entry
  - Agreement: atm program
  - Counterparty: Cantor Fitzgerald & Co. and B. Riley Securities, Inc.
  - Value: up to $40 million
  - Effective: 2022-12-23
  source text: On December 23, 2022, Cognition Therapeutics, Inc. (the “Company”), entered into a Controlled Equity Offering SM Sales Agreement (the “Sales Agreement”) with Cantor Fitzgerald & Co. and B. Riley Securities, Inc. (each, an “Agent”, and together the “Agents”), under which the Company may offer and sell, from time to time at its sole discretion, shares of its common stock, par value $0.001 per share (the “Shares”), having an aggregate offering price of up to $40 million through or to the Agents.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1455365/000110465922129912/0001104659-22-129912-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.